Oisin Biotechnologies

Biopharma, Biotechnology, Medical
Founded in 2014-01-01
Seattle, Washington, United States
http://www.oisinbio.com
For Profit

About Oisin Biotechnologies

Oisin Biotechnologies is a platform drug development company focused on creating drugs to combat a variety of age-related diseases. It is developing a highly precise, patent-pending, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces the negative effects of aging pathologies and also extends the median lifespan and survival. Oisin Biotechnologies was founded in 2014 and is headquartered in Seattle, Washington.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 7118936 USD
  • Last Funding: 5000000 USD (Seed)
  • Funding Status: Seed

Technology Stack

Oisin Biotechnologies actively uses None products in their tech stack.

Market Presence

Industries: Biopharma, Biotechnology, Medical

Headquarters: Seattle, Washington, United States